From Breakthroughs Blog: Featured Posts

Passing the ball: DNDi transfers malaria therapies to MMV

The Drugs for Neglected Disease initiative (DNDi) and the Medicines for Malaria Venture (MMV)—nonprofit product development partnerships (PDPs) and members of the Global Health Technologies Coalition—have teamed up to ensure two treatments for malaria continue to reach the patients who need them most.

Read More
Innovation. Transformation. Inspiration. Part 1

This post was originally featured on on January 27, 2013 and was written by PATH’s Drug Development program.

Read More